株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

癌診断市場の分析レポート:種類別(臨床試験、遺伝子検査、画像検査、内視鏡検査)、用途別(乳癌、肺癌、肝臓癌、子宮癌、大腸癌、皮膚癌)、地域別、セグメント予測

Cancer Diagnostics Market Analysis Report By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 408926
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.21円で換算しております。
Back to Top
癌診断市場の分析レポート:種類別(臨床試験、遺伝子検査、画像検査、内視鏡検査)、用途別(乳癌、肺癌、肝臓癌、子宮癌、大腸癌、皮膚癌)、地域別、セグメント予測 Cancer Diagnostics Market Analysis Report By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年02月14日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界の癌診断市場について調査分析を行い、市場概要、市場動向、市場のダイナミクスなどについて考察するとともに、種類別、用途別、地域別に市場を包括的に分析し、まとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場の見通し
  • 市場浸透と成長予測マッピング
  • バリューチェーン分析
  • 技術の概要
  • 規制の枠組み
  • 市場のダイナミクス
  • 市場分析ツール

第4章 癌診断市場:競合分析

  • 最近の発展と影響分析:主要企業別
  • ベンダーの状況
  • 株式公開企業
  • 株式未公開企業

第5章 癌診断市場:種類の予測と動向分析

  • 定義と範囲
  • 種類別市場シェア分析
  • セグメントダッシュボード
  • 世界の抗生物質市場:種類別
  • 市場規模と予測、動向分析
    • 臨床試験
    • 遺伝子検査
    • 画像検査
    • 内視鏡検査
    • 生検
    • その他

第6章 癌診断市場:用途の予測と動向分析

  • 定義と範囲
  • 用途別市場シェア分析
  • セグメントダッシュボード
  • 世界の抗生物質市場:用途別
  • 市場規模と予測、動向分析
    • 乳癌
    • 大腸癌
    • 子宮癌
    • 肺癌
    • 前立腺癌
    • 皮膚癌
    • 血液癌
    • 腎臓癌
    • 肝臓癌
    • すい臓癌
    • 卵巣癌
    • その他

第7章 癌診断市場:地域の予測と動向分析

  • 地域市場の概要
  • 地域市場のシェアと主要企業
  • 市場シェア分析:国別/州別
  • SWOT分析:因子別
  • 市場規模と予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東/アフリカ

第8章 企業プロファイル

  • Abbott Laboratories
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Becton Dickinson & Company
  • Koninklijke Philips N.V. (Philips)
  • Illumina, Inc.
図表

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies' /technology disruptors/innovators
  • Table 3 North America cancer diagnostics market, by countries, 2014 - 2026 (USD Million)
  • Table 4 North America cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 5 North America cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 6 North America breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 7 North America colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 8 North America cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 9 North America lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 10 North America prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 11 North America skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 12 North America blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 13 North America kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 14 North America liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 15 North America pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 16 North America ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 17 North America other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 18 U.S. cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 19 U.S. cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 20 U.S. breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 21 U.S. colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 22 U.S. cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 23 U.S. lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 24 U.S. prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 25 U.S. skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 26 U.S. blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 27 U.S. kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 28 U.S. liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 29 U.S. pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 30 U.S. ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 31 U.S. other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 32 Canada cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 33 Canada cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 34 Canada breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 35 Canada colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 36 Canada cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 37 Canada lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 38 Canada prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 39 Canada skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 40 Canada blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 41 Canada kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 42 Canada liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 43 Canada pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 44 Canada ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 45 Canada other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 46 Europe cancer diagnostics market, by countries, 2014 - 2026 (USD Million)
  • Table 47 Europe cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 48 Europe cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 49 Europe breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 50 Europe colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 51 Europe cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 52 Europe lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 53 Europe prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 54 Europe skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 55 Europe blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 56 Europe kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 57 Europe liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 58 Europe pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 59 Europe ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 60 Europe other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 61 U.K. cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 62 U.K. cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 63 U.K. breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 64 U.K. colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 65 U.K. cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 66 U.K. lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 67 U.K. prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 68 U.K. skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 69 U.K. blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 70 U.K. kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 71 U.K. liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 72 U.K. pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 73 U.K. ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 74 U.K. other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 75 Germany cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 76 Germany cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 77 Germany breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 78 Germany colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 79 Germany cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 80 Germany lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 81 Germany prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 82 Germany skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 83 Germany blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 84 Germany kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 85 Germany liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 86 Germany pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 87 Germany ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 88 Germany other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 89 Italy cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 90 Italy cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 91 Italy breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 92 Italy colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 93 Italy cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 94 Italy lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 95 Italy prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 96 Italy skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 97 Italy blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 98 Italy kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 99 Italy liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 100 Italy pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 101 Italy ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 102 Italy other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 103 Spain cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 104 Spain cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 105 Spain breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 106 Spain colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 107 Spain cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 108 Spain lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 109 Spain prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 110 Spain skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 111 Spain blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 112 Spain kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 113 Spain liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 114 Spain pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 115 Spain ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 116 Spain other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 117 France cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 118 France cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 119 France breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 120 France colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 121 France cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 122 France lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 123 France prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 124 France skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 125 France blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 126 France kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 127 France liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 128 France pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 129 France ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 130 France other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 131 Asia Pacific cancer diagnostics market, by countries, 2014 - 2026 (USD Million)
  • Table 132 Asia Pacific cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 133 Asia Pacific cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 134 Asia Pacific breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 135 Asia Pacific colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 136 Asia Pacific cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 137 Asia Pacific lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 138 Asia Pacific prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 139 Asia Pacific skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 140 Asia Pacific blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 141 Asia Pacific kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 142 Asia Pacific liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 143 Asia Pacific pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 144 Asia Pacific ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 145 Asia Pacific other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 146 China cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 147 China cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 148 China breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 149 China colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 150 China cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 151 China lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 152 China prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 153 China skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 154 China blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 155 China kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 156 China liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 157 China pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 158 China ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 159 China other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 160 Japan cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 161 Japan cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 162 Japan breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 163 Japan colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 164 Japan cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 165 Japan lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 166 Japan prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 167 Japan skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 168 Japan blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 169 Japan kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 170 Japan liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 171 Japan pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 172 Japan ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 173 Japan other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 174 India cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 175 India cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 176 India breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 177 India colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 178 India cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 179 India lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 180 India prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 181 India skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 182 India blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 183 India kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 184 India liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 185 India pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 186 India ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 187 India other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 188 Thailand cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 189 Thailand cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 190 Thailand breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 191 Thailand colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 192 Thailand cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 193 Thailand lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 194 Thailand prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 195 Thailand skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 196 Thailand blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 197 Thailand kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 198 Thailand liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 199 Thailand pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 200 Thailand ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 201 Thailand other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 202 South Korea cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 203 South Korea cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 204 South Korea breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 205 South Korea colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 206 South Korea cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 207 South Korea lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 208 South Korea prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 209 South Korea skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 210 South Korea blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 211 South Korea kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 212 South Korea liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 213 South Korea pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 214 South Korea ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 215 South Korea other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 216 Latin America cancer diagnostics market, by countries, 2014 - 2026 (USD Million)
  • Table 217 Latin America cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 218 Latin America cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 219 Latin America breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 220 Latin America colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 221 Latin America cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 222 Latin America lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 223 Latin America prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 224 Latin America skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 225 Latin America blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 226 Latin America kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 227 Latin America liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 228 Latin America pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 229 Latin America ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 230 Latin America other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 231 Brazil cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 232 Brazil cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 233 Brazil breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 234 Brazil colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 235 Brazil cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 236 Brazil lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 237 Brazil prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 238 Brazil skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 239 Brazil blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 240 Brazil kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 241 Brazil liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 242 Brazil pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 243 Brazil ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 244 Brazil other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 245 Mexico cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 246 Mexico cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 247 Mexico breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 248 Mexico colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 249 Mexico cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 250 Mexico lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 251 Mexico prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 252 Mexico skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 253 Mexico blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 254 Mexico kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 255 Mexico liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 256 Mexico pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 257 Mexico ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 258 Mexico other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 259 Argentina cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 260 Argentina cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 261 Argentina breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 262 Argentina colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 263 Argentina cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 264 Argentina lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 265 Argentina prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 266 Argentina skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 267 Argentina blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 268 Argentina kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 269 Argentina liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 270 Argentina pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 271 Argentina ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 272 Argentina other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 273 Columbia cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 274 Columbia cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 275 Columbia breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 276 Columbia colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 277 Columbia cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 278 Columbia lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 279 Columbia prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 280 Columbia skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 281 Columbia blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 282 Columbia kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 283 Columbia liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 284 Columbia pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 285 Columbia ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 286 Columbia other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 287 Middle East and Africa cancer diagnostics market, by countries, 2014 - 2026 (USD Million)
  • Table 288 Middle East and Africa cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 289 Middle East and Africa cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 290 Middle East and Africa breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 291 Middle East and Africa colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 292 Middle East and Africa cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 293 Middle East and Africa lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 294 Middle East and Africa prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 295 Middle East and Africa skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 296 Middle East and Africa blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 297 Middle East and Africa kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 298 Middle East and Africa liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 299 Middle East and Africa pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 300 Middle East and Africa ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 301 Middle East and Africa other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 302 South Africa cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 303 South Africa cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 304 South Africa breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 305 South Africa colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 306 South Africa cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 307 South Africa lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 308 South Africa prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 309 South Africa skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 310 South Africa blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 311 South Africa kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 312 South Africa liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 313 South Africa pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 314 South Africa ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 315 South Africa other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 316 Saudi Arabia cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 317 Saudi Arabia cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 318 Saudi Arabia breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 319 Saudi Arabia colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 320 Saudi Arabia cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 321 Saudi Arabia lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 322 Saudi Arabia prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 323 Saudi Arabia skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 324 Saudi Arabia blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 325 Saudi Arabia kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 326 Saudi Arabia liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 327 Saudi Arabia pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 328 Saudi Arabia ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 329 Saudi Arabia other cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 330 UAE cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 331 UAE cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Table 332 UAE breast cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 333 UAE colorectal cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 334 UAE cervical cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 335 UAE lung cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 336 UAE prostate cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 337 UAE skin cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 338 UAE blood cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 339 UAE kidney cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 340 UAE liver cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 341 UAE pancreatic cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 342 UAE ovarian cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Table 343 UAE other cancer diagnostics market, by type, 2014 - 2026 (USD Million

List of Figures

  • Fig.1 Cancer diagnostics market segmentation
  • Fig.2 Information procurement
  • Fig.3 Market research process
  • Fig.4 Primary research pattern
  • Fig.5 Market research approaches
  • Fig.6 Value chain based sizing & forecasting
  • Fig.7 QFD modelling for market share assessment
  • Fig.8 Cancer diagnostics market snapshot (2018)
  • Fig.9 Cancer diagnostics market: Segment snapshot (2018)
  • Fig.10 Competitive Insights (2018)
  • Fig.11 Parent market outlook
  • Fig.12 Related/ancillary market outlook
  • Fig.13 Penetration and growth prospect mapping
  • Fig.14 Industry value chain analysis
  • Fig.15 Technology timeline
  • Fig.16 Cancer diagnostics market driver impact
  • Fig.17 Cancer diagnostics market restraint impact
  • Fig.18 Cancer diagnostics industry challenges
  • Fig.19 Recent Developments & Impact Analysis, By Key Market Participants
  • Fig.20 Key company market share analysis, 2018
  • Fig.21 Company market position analysis
  • Fig.22 Company Market Share/Ranking, by region
  • Fig.23 Competitive dashboard analysis
  • Fig.24 Company market position analysis
  • Fig.25 Supplier Ranking
  • Fig.26 Definition and Scope, by type
  • Fig.27 Type market share analysis, 2018 & 2026
  • Fig.28 Segment Dashboard
  • Fig.29 Global cancer diagnostics market, by type, 2014 - 2026 (USD Million)
  • Fig.30 Laboratory tests market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.31 Genetic tests market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.32 Imaging market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.33 Endoscopy market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.34 Biopsy market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.35 Others market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.36 Definition and Scope, by application
  • Fig.37 Application market share analysis, 2018 & 2026
  • Fig.38 Segment Dashboard
  • Fig.39 Global cancer diagnostics market, by application, 2014 - 2026 (USD Million)
  • Fig.40 Breast Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.41 Breast Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.42 Colorectal Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.43 Colorectal Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.44 Cervical Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.45 Cervical Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.46 Lung Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.47 Lung Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.48 Prostate Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.49 Prostate Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.50 Skin Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.51 Skin Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.52 Blood Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.53 Blood Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.54 Kidney Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.55 Kidney Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.56 Liver Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.57 Liver Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.58 Pancreatic Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.59 Pancreatic Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.60 Ovarian Cancer market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.61 Ovarian Cancer market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.62 Others market size & forecasts and trend analyses, 2014 to 2026 (USD Million)
  • Fig.63 Others market size & forecasts and trend analyses, by type 2014 to 2026 (USD Million)
  • Fig.64 Cancer diagnostics market: Snapshot, 2018
  • Fig.65 North America cancer diagnostics market share and leading players, 2018
  • Fig.66 Europe cancer diagnostics market share and leading players, 2018
  • Fig.67 Asia Pacific cancer diagnostics market share and leading players, 2018
  • Fig.68 Latin America cancer diagnostics market share and leading players, 2018
  • Fig.69 Middle East and Africa cancer diagnostics market share and leading players, 2018
  • Fig.70 North America market share analysis by country, 2018
  • Fig.71 Europe market share analysis by country, 2018
  • Fig.72 Asia Pacific market share analysis by country, 2018
  • Fig.73 Latin America market share analysis by country, 2018
  • Fig.74 Middle East and Africa market share analysis by country, 2018
  • Fig.75 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.76 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.77 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.78 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.79 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig.80 North America market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.81 U.S. market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.82 Canada market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.83 Europe market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.84 UK market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.85 Germany market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.86 Italy market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.87 Spain market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.88 France market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.89 Asia Pacific market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.90 China market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.91 Japan market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.92 India market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.93 Thailand market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.94 South Korea market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.95 Latin America market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.96 Brazil market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.97 Mexico market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.98 Argentina market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.99 Columbia market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.100 Middle East and Africa market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.101 South Africa market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.102 Saudi Arabia market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
  • Fig.103 UAE market size, & forecasts and trend analysis, 2014 TO 2026 (USD Million)
目次
Product Code: GVR-1-68038-213-6

The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Further key findings from the report suggest:

  • Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
  • The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
  • In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region

Major players competing in this market include: GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.

Table of Contents

Chapter 1: Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Industry Value Chain Analysis
    • 3.3.1 Raw Material Trends
      • 3.3.1.1 Major Raw Materials Market Analysis
      • 3.3.1.2 Procurement Best Practices
    • 3.3.2 Manufacturing Trends
      • 3.3.2.1 Technology Trends
      • 3.3.2.2 Outsourcing & Contract Manufacturing Trends
      • 3.3.2.3 Cost Structure Analysis
    • 3.3.3 User perspective analysis
      • 3.3.3.1 Consumer Behavior Analysis
      • 3.3.3.2 Market Influencer Analysis
    • 3.3.4 Procedure cost analysis/breakdown
    • 3.3.5 List of Key End-users, by region / by product / by country
  • 3.4 Technology Overview
    • 3.4.1 Technology Timeline
  • 3.5 Regulatory Framework
    • 3.5.1 Reimbursement framework
    • 3.5.2 Standards & Compliances
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
    • 3.6.2 Market Restraint Analysis
    • 3.6.3 Industry Challenges
  • 3.7 Cancer Diagnostics Market Analysis Tools
    • 3.7.1 Industry Analysis - Porter's
      • 3.7.1.1 Supplier Power (low; large number of small scale suppliers)
      • 3.7.1.2 Buyer Power (High; high adoption of advanced technology)
      • 3.7.1.3 Substitution Threat (Moderate; frequent new product launches)
      • 3.7.1.4 Threat from new entrant (Moderate; Stringent norms to restrict entrants)
      • 3.7.1.5 Competitive rivalry (High; consolidated market)
    • 3.7.2 PESTEL Analysis
      • 3.7.2.1 Political Landscape
      • 3.7.2.2 Environmental Landscape
      • 3.7.2.3 Social Landscape
      • 3.7.2.4 Technology Landscape
      • 3.7.2.5 Legal Landscape
    • 3.7.3 Major Deals & Strategic Alliances Analysis
      • 3.7.3.1 Joint Ventures
      • 3.7.3.2 Mergers & Acquisitions
      • 3.7.3.3 Licensing & Partnership
      • 3.7.3.4 Technology Collaborations
      • 3.7.3.5 Strategic Divestments
    • 3.7.4 Market Entry Strategies
    • 3.7.5 Case Studies

Chapter 4: Cancer Diagnostics Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key customers
    • 4.2.3 Key company market share analysis, 2018
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Company Market Share/Ranking, by region
    • 4.3.3 Competitive Dashboard Analysis
      • 4.3.3.1 Market Differentiators
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies' /technology disruptors/innovators
    • 4.4.2 Funding Outlook
    • 4.4.3 Regional network map
    • 4.4.4 Company market position analysis
    • 4.4.5 Supplier Ranking

Chapter 5: Cancer Diagnostics Market: Type Estimates and Trend Analysis

  • 5.1 Definition and Scope
  • 5.2 Type Market Share Analysis, 2018 & 2026
  • 5.3 Segment Dashboard
  • 5.4 Global Cancer Diagnostics Market, by Type, 2014 - 2026 (USD Million)
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Type
    • 5.5.1 Laboratory Tests
      • 5.5.1.1 Laboratory Tests Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
    • 5.5.2 Genetic Tests
      • 5.5.2.1 Genetic Tests Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
    • 5.5.3 Imaging
      • 5.5.3.1 Imaging Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
    • 5.5.4 Endoscopy
      • 5.5.4.1 Endoscopy Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
    • 5.5.5 Biopsy
      • 5.5.5.1 Biopsy Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Others Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million)

Chapter 6: Cancer Diagnostics Market: Application Estimates And Trend Analysis

  • 6.1 Definition And Scope
  • 6.2 Application Market Share Analysis, 2018 & 2026
  • 6.3 Segment Dashboard
  • 6.4 Global Cancer Diagnostics Market, By Application, 2014-2026 (USD Million)
  • 6.5 Market Size & Forecasts And Trend Analyses, 2014 To 2026, By Application
    • 6.5.1 Breast Cancer
      • 6.5.1.1 Breast Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.1.2 Breast Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.2 Colorectal Cancer
      • 6.5.2.1 Colorectal Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.2.2 Colorectal Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.3 Cervical Cancer
      • 6.5.3.1 Cervical Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.3.2 Cervical Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.4 Lung Cancer
      • 6.5.4.1 Lung Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.4.2 Lung Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.5 Prostate Cancer
      • 6.5.5.1 Prostate Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026(USD Million)
      • 6.5.5.2 Prostate Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.6 Skin Cancer
      • 6.5.6.1 Skin Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.6.2 Skin Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.7 Blood Cancer
      • 6.5.7.1 Blood Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.7.2 Blood Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.8 Kidney Cancer
      • 6.5.8.1 Kidney Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.8.2 Kidney Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.9 Liver Cancer
      • 6.5.9.1 Liver Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.9.2 Liver Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.10 Pancreatic Cancer
      • 6.5.10.1 Pancreatic Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.10.2 Pancreatic Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.11 Ovarian Cancer
      • 6.5.11.1 Ovarian Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.11.2 Ovarian Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million)
    • 6.5.12 Others
      • 6.5.12.1 Others Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
      • 6.5.12.2 Others Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026(USD Million)

Chapter 7: Cancer Diagnostics Market Regional Estimates & Trend Analysis, by Product & Application

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share and Leading Players, 2018
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Asia Pacific
    • 7.2.4 Latin America
    • 7.2.5 Middle East & Africa
  • 7.3 Market Share Analysis by Country/ State
    • 7.3.1 North America
    • 7.3.2 Europe
    • 7.3.3 Asia Pacific
    • 7.3.4 Latin America
    • 7.3.5 Middle East & Africa
  • 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Asia Pacific
    • 7.4.4 Latin America
    • 7.4.5 Middle East & Africa
  • 7.5 Market Size, & Forecasts and Trend Analysis, 2014 TO 2026
  • 7.6 North America
    • 7.6.1 North America Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.6.2 U.S.
      • 7.6.2.1 U.S. Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.6.3 Canada
      • 7.6.3.1 Canada Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
  • 7.7 Europe
    • 7.7.1 Europe Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.7.2 U.K.
      • 7.7.2.1 U.K. Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.7.3 Germany
      • 7.7.3.1 Germany Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.7.4 Italy
      • 7.7.4.1 Italy Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.7.5 Spain
      • 7.7.5.1 Spain Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.7.6 France
      • 7.7.6.1 France Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
  • 7.8 Asia Pacific
    • 7.8.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.8.2 China
      • 7.8.2.1 China Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.8.3 Japan
      • 7.8.3.1 Japan Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.8.4 India
      • 7.8.4.1 India Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.8.5 Thailand
      • 7.8.5.1 Thailand market size, & forecasts and trend analysis, 2014 to 2026 (usd million)
    • 7.8.6 South Korea
      • 7.8.6.1 South Korea Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
  • 7.9 Latin America
    • 7.9.1 Latin America Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.9.2 Brazil
      • 7.9.2.1 Brazil Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.9.3 Mexico
      • 7.9.3.1 Mexico Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.9.4 Argentina
      • 7.9.4.1 Argentina Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.9.5 Columbia
      • 7.9.5.1 Columbia Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
  • 7.10 Middle East and Africa
    • 7.10.1 Middle East and Africa Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.10.2 South Africa
      • 7.10.2.1 South Africa Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.10.3 Saudi Arabia
      • 7.10.3.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
    • 7.10.4 UAE
      • 7.10.4.1 UAE Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)

Chapter 8: Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company overview
    • 8.1.2 Financial performance
    • 8.1.3 Product benchmarking
    • 8.1.4 Strategic initiatives
  • 8.2 Qiagen N.V.
    • 8.2.1 Company overview
    • 8.2.2 Financial performance
    • 8.2.3 Product benchmarking
    • 8.2.4 Strategic initiatives
  • 8.3 F. Hoffmann-La Roche Ltd.
    • 8.3.1 Company overview
    • 8.3.2 Financial performance
    • 8.3.3 Product benchmarking
    • 8.3.4 Strategic initiatives
  • 8.4 Siemens Healthineers
    • 8.4.1 Company overview
    • 8.4.2 Financial performance
    • 8.4.3 Product benchmarking
    • 8.4.4 Strategic initiatives
  • 8.5 Thermo Fisher Scientific, Inc.
    • 8.5.1 Company overview
    • 8.5.2 Financial performance
    • 8.5.3 Product benchmarking
    • 8.5.4 Strategic initiatives
  • 8.6 GE Healthcare
    • 8.6.1 Company overview
    • 8.6.2 Financial performance
    • 8.6.3 Product benchmarking
    • 8.6.4 Strategic initiatives
  • 8.7 Hologic, Inc.
    • 8.7.1 Company overview
    • 8.7.2 Financial performance
    • 8.7.3 Product benchmarking
    • 8.7.4 Strategic initiatives
  • 8.8 Becton Dickinson & Company
    • 8.8.1 Company overview
    • 8.8.2 Financial performance
    • 8.8.3 Product benchmarking
    • 8.8.4 Strategic initiatives
  • 8.9 Koninklijke Philips N.V. (Philips)
    • 8.9.1 Company overview
    • 8.9.2 Financial performance
    • 8.9.3 Product benchmarking
    • 8.9.4 Strategic initiatives
  • 8.10 Illumina, Inc.
    • 8.10.1 Company overview
    • 8.10.2 Financial performance
    • 8.10.3 Product benchmarking
    • 8.10.4 Strategic initiatives
Back to Top